Cargando…

Impact of the 2019 Coronavirus Infectious Disease (COVID-19) pandemic on onset to door time and admissions of new onset acute ischemic stroke in a tertiary care level hospital in North India

CONTEXT: Coronavirus infectious disease (COVID-19) pandemic disrupted the already marginalized healthcare provision in resource limited countries like India. AIMS: This study compared onset to door time and temporal trends of admissions to seek medical care in new onset acute ischaemic stroke during...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulena, Kataria, Urvashi, Bhatt, Rajat, Sharma, Ashish, Arora, Hobinder, Kaushal, Himanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480786/
https://www.ncbi.nlm.nih.gov/pubmed/36119293
http://dx.doi.org/10.4103/jfmpc.jfmpc_2398_21
Descripción
Sumario:CONTEXT: Coronavirus infectious disease (COVID-19) pandemic disrupted the already marginalized healthcare provision in resource limited countries like India. AIMS: This study compared onset to door time and temporal trends of admissions to seek medical care in new onset acute ischaemic stroke during the COVID-19 period with a representative pre-COVID-19 period in rural background. SETTINGS AND DESIGN: Prospective Cross-sectional study in a tertiary level hospital in North India. METHODS AND MATERIAL: Study included new onset acute ischaemic stroke admitted within first 2 weeks of symptoms onset. Subjects were divided into: Group A – Pre-COVID-19 stroke, Group B – Non-COVID-19 Stroke, and Group C - Stroke, positive for COVID-19. Detailed epidemiological, clinical profile, onset to door time and temporal trends of admissions were recorded. STATISTICAL ANALYSIS USED: Chi square/Fisher’s exact test and Independent Samples T test or Mann–Whitney U test were used for categorical and continuous variables. RESULTS: Onset to door time in new onset acute ischaemic stroke was significantly prolonged by 6 h in COVID-19 period (median (interquartile range), 19 (12–27) h) as compared with pre-COVID-19 period. Admissions of new onset acute ischaemic stroke were significantly less in COVID-19 period. Comorbidities and severity of stroke (mean National Institutes of Health Stroke Scale, 20 ± 4) were more during the COVID-19 period. Incidence and mortality of COVID-19 positive new onset acute ischaemic stroke were 0.95% and 38%. CONCLUSIONS: Onset to door time in new onset acute ischaemic stroke was significantly prolonged in COVID-19 as compared with pre-COVID-19 period. The admissions were fewer with more severity and comorbidities in COVID-19 period. COVID-19 positive stroke patients had more severity and mortality as compared with non-COVID-19 stroke.